Title:
APPLICATION OF CD93 IN PREPARING CORD BLOOD TEST KIT FOR EARLY WARNING INFANTILE HEMANGIOMA AND THERAPEUTIC DRUG
Document Type and Number:
WIPO Patent Application WO/2019/206122
Kind Code:
A1
Abstract:
Application of CD93 in preparing a cord blood test kit for early warning infantile hemangioma (IH), in preparing a drug for treating or preventing IH, and in preparing a serum marker for preventing hemangioma. The cord blood test kit with CD93 as a predictive/early-warning protein can early warn the occurrence of IH, so that IH can be early monitored, early detected, and early treated. In addition, CD93, as a transmembrane protein, can promote hemangioma stem cell angiogenesis, has important significance for an anti-angiogenesis therapeutic target, and can be used for early treatment and prevention of IH.
Inventors:
JIANG CHENGHONG (CN)
Application Number:
PCT/CN2019/083833
Publication Date:
October 31, 2019
Filing Date:
April 23, 2019
Export Citation:
Assignee:
JIANG CHENGHONG (CN)
International Classes:
G01N33/68; C12Q1/68
Domestic Patent References:
| WO2018020222A2 | 2018-02-01 | |||
| WO2018144070A1 | 2018-08-09 | |||
| WO2002033043A2 | 2002-04-25 |
Foreign References:
| EP2392352A2 | 2011-12-07 |
Other References:
LIU, YU ET AL.: "The Expression of Estrogen Receptor and Several Angiogenesis Factors in Hemangioma and Vascular Malformation", ANATOMY AND CLINICS, vol. 5, no. 4, 30 April 2005 (2005-04-30)
Attorney, Agent or Firm:
SHANGHAI ESSEN PATENT & TRADEMARK OFFICE (CN)
Download PDF:
Previous Patent: MANUFACTURING METHOD AND DEVICE OF FLOW BATTERY ELECTROLYTE
Next Patent: MOBILE TERMINAL
Next Patent: MOBILE TERMINAL